LL-37, human | Antimicrobial Peptide

Cat. No.: HY-P1222

6 Cited Publications

Customer Review

Based on 6 publication(s) in Google Scholar

LL-37, human is a 37-residue, amphipathic, cathelicidin-derived antimicrobial peptide, which exhibits a broad spectrum of antimicrobial activity. LL-37, human could help protect the cornea from infection and modulates wound healing.

For research use only. We do not sell to patients.

• Purity: 99.82%
• CAS No.: 154947-66-7
• Formula: C205H340N60O53
• Molecular Weight:4493.26

• Storage:

  Sealed storage, away from moisture and light, under nitrogen.

  Powder   -80°C, 2 years , -20°C, 1 year

  * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen)

• HY-P1539

  Cecropin A

• HY-A0276A

  Gentamicin

• HY-P0201

  Substance P

• HY-P4855

  CRAMP (mouse)

• HY-13259

  MG-132

• HY-15142

  Doxorubicin hydrochloride

• HY-B0015

  Paclitaxel

• HY-10219

  Rapamycin

• HY-17026

  Gemcitabine

• HY-B0011

  Docetaxel

• HY-P0267

  Melanotan (MT)-II

• HY-10431

  SB-431542

Customer Validation & Images

2D/3D Cell Culture and DifferentiationIn Vivo Efficacy StudyRT-PCRCell Imaging/StainingHistological Imaging/StainingCell Migration/Invasion AssayELISABio/Physico-chemical Assay

• 2D/3D Cell Culture and Differentiation

• 2D/3D Cell Culture and Differentiation

• Cell Imaging/Staining

• Cell Migration/Invasion Assay

• ELISA

Keywords

MOQ

Minimum order quantity

100 mg

Get Quote In-stock

Other size

Get Quote

Please select quantity

Amount: USD 0.00

Sign in to MedChemExpress Sign In

Register

Register New Account

At least 6 characters

Assay Types

• 1/16

  LL-37, human purchased from MedChemExpress. Usage Cited in: ACS Omega. 2025 Aug 12;10(33):36994-37003. [Abstract]

  Customer Validation
  LL-37 (50 μM, 24 h) demonstrated effective photodamage repair, increasing the survival of UVB-irradiated HaCaT cells by 14.6% and UVA-irradiated HDF cells by 11.8%.

• 1/16

  LL-37, human purchased from MedChemExpress. Usage Cited in: Int Immunopharmacol. 2024 Mar 10:129:111636. [Abstract]

  Customer Validation
  LL-37, human TFA (320 μM; 40 μL; every 12 h for 2 d) generated the redness and telangiectasis in the skin of BALB/c mice, with increased range of redness and the redness score.

• 1/16

  LL-37, human purchased from MedChemExpress. Usage Cited in: Int Immunopharmacol. 2024 Mar 10:129:111636. [Abstract]

  Customer Validation
  The present study employed OCT to examine the structural characteristics of the skin of BALB/c mice treated with LL-37, human TFA (320 μM; 40 μL; every 12 h for 2 d).

• 1/16

  LL-37, human purchased from MedChemExpress. Usage Cited in: Int Immunopharmacol. 2024 Mar 10:129:111636. [Abstract]

  Customer Validation
  LL-37, human TFA (320 μM; 40 μL; every 12 h for 2 d) caused a statistically significant increase in the presence of CD4+T cells and MCs within the dermis of BALB/c mice.